chr4-55636132-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006681.4(NMU):āc.61C>Gā(p.Pro21Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000082 in 1,524,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006681.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NMU | NM_006681.4 | c.61C>G | p.Pro21Ala | missense_variant | 1/10 | ENST00000264218.7 | NP_006672.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NMU | ENST00000264218.7 | c.61C>G | p.Pro21Ala | missense_variant | 1/10 | 1 | NM_006681.4 | ENSP00000264218.3 |
Frequencies
GnomAD3 genomes AF: 0.000421 AC: 64AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000641 AC: 8AN: 124854Hom.: 0 AF XY: 0.0000292 AC XY: 2AN XY: 68528
GnomAD4 exome AF: 0.0000444 AC: 61AN: 1372676Hom.: 0 Cov.: 32 AF XY: 0.0000443 AC XY: 30AN XY: 677138
GnomAD4 genome AF: 0.000420 AC: 64AN: 152304Hom.: 0 Cov.: 33 AF XY: 0.000443 AC XY: 33AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2023 | The c.61C>G (p.P21A) alteration is located in exon 1 (coding exon 1) of the NMU gene. This alteration results from a C to G substitution at nucleotide position 61, causing the proline (P) at amino acid position 21 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at